Marvel Biosciences’ lead therapeutic candidate, MB-204 receives Japanese patent: Calgary, Alberta Thursday, February 5, 2026, 10:00 Hrs [IST] Marvel Biosciences Corporation and ...
The study, which assessed the pharmacokinetics, safety, tolerability and immunogenicity of AVT80 compared to Entyvio® in ...
Vietnam Investment Review on MSN
Everest Medicines licenses MT1013 from Micot
SHANGHAI, Feb. 5, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and ...
Afghanistan has plunged deeper into a crisis marked by levels of child hunger unseen in 25 years and the closure of almost 450 health centers.
Systems weren’t built for neurodiversity. This post shows how psychology helps us shift from compliance to belonging for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results